You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨雲頂新耀-B大漲近20% 股價站上60港元創近3年半新高 AI製藥驅動估值重估
格隆匯 03-07 13:28
雲頂新耀-B(1952.HK)今日高開高走,盤中一度大漲19.13%至60.1港元,股價創2021年9月28日以來近3年半新高,市值達196.5億港元。消息面上,雲頂新耀昨日宣佈其自主研發的首款AI驅動mRNA個性化腫瘤疫苗EVM16在北京大學腫瘤醫院完成首例患者給藥,表明雲頂新耀具有自主知識產權的腫瘤新抗原人工智能(AI)算法系統和經過臨牀驗證的mRNA技術平臺已成功進入人體試驗階段。據悉,這款疫苗依託公司獨有的EVER-NEO-1“妙算”AI系統,通過分析患者腫瘤突變特徵,篩選出具有高免疫原性的新抗原,進而設計出編碼數十種靶點的mRNA疫苗。中信建投認爲,AI製藥(AIDD)已滲透至靶點發現、分子設計、毒性預測等全流程,大幅提升早期研發效率。(格隆匯)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account